DTC
OCUL icon

Deep Track Capital’s Ocular Therapeutix OCUL Stock Holding History

Deep Track Capital’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$193M Hold
19,686,282
– – 2.81% 10
2026
Q1 		$167M Buy
19,686,282
+11,615,868
+144% +$111M 2.72% 9
2025
Q4 		$98M Sell
8,070,414
-3,861,723
-32% -$46.9M 1.75% 17
2025
Q3 		$139M Sell
11,932,137
-2,362,283
-17% -$28.2M 3.89% 9
2025
Q2 		$133M Hold
14,294,420
– – 4.25% 8
2025
Q1 		$105M Buy
14,294,420
+1,458,138
+11% +$11.2M 3.39% 10
2024
Q4 		$110M Buy
12,836,282
+114,822
+0.9% +$1.12M 4.09% 8
2024
Q3 		$111M Hold
12,721,460
– – 3.51% 9
2024
Q2 		$87M Hold
12,721,460
– – 2.6% 14
2024
Q1 		$116M Buy
12,721,460
+3,490,691
+38% +$24.8M 3.32% 10
2023
Q4 		$41.2M Buy
+9,230,769
New +$27.3M 1.37% 32

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deep Track Capital's OCUL Position: Q2 2026 in Review

Deep Track Capital held its Ocular Therapeutix (OCUL) position steady in Q2 2026 at 19,686,282 shares worth $193M. The position accounts for 2.81% of the portfolio, ranked #10.

Deep Track Capital first reported a position in OCUL in Q4 2023 and has held it in 11 quarters since. 262 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Deep Track Capital held 19,686,282 shares of Ocular Therapeutix worth $193M as of Q2 2026.
  • Deep Track Capital left its Ocular Therapeutix share count unchanged in Q2 2026.
  • Ocular Therapeutix made up 2.81% of Deep Track Capital's portfolio in Q2 2026, its #10 holding.
  • Deep Track Capital first reported a position in Ocular Therapeutix in Q4 2023 and has held it in 11 quarters since.
  • 262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Deep Track Capital's 13F filing for Q2 2026, filed 14 Aug 2026.